Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;161(7):768-770.
doi: 10.1001/jamadermatol.2025.0924.

Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell Lymphoma

Vrusha K Shah  1 , Sara Behbahani  2 , Jeffrey Barnes  3 , Katherine Perlman  2   4 , Steven T Chen  2
Affiliations

Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell Lymphoma

Vrusha K Shah et al. JAMA Dermatol. .
No abstract available

Plain language summary

This cohort study assessed the risk factors for a second primary solid or hematologic cancer in patients with primary cutaneous B-cell lymphoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

References

    1. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268 - DOI - PMC - PubMed
    1. Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol. 2015;90(5):687-706. doi: 10.1590/abd1806-4841.20153638 - DOI - PMC - PubMed
    1. Milano AF. Non-Hodgkin lymphoma—nodal and extranodal: 20-year comparative mortality, survival & biologic behavior analysis by age, sex, race, stage, cell morphology/histology, cohort entry time-period and disease duration: a systematic review of 384,651 total NHL cases including 261,144 nodal and 123,507 extranodal cases for diagnosis years 1975-2016: (SEER*Stat 8.3.6). J Insur Med. 2023;50(1):1-35. doi: 10.17849/insm-50-1-1-35.1 - DOI - PubMed
    1. Goyal A, O’Leary D, Goyal K, et al. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: a Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol. 2020;83(2):404-411. doi: 10.1016/j.jaad.2019.07.075 - DOI - PMC - PubMed
    1. Banner L, Joffe D, Lee E, Porcu P, Nikbakht N. Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry. Front Med (Lausanne). 2023;10:1110511. doi: 10.3389/fmed.2023.1110511 - DOI - PMC - PubMed

LinkOut - more resources